| Financial Year |
March 31 2023 |
| Monetary Funds |
41,085,091.57 |
| Held-for-trading Financial Assets |
47,485,557.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
194,578,286.48 |
| Advances to Suppliers |
24,671,947.96 |
| Other Receivables |
59,618,139.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
69,032,219.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
19,496,462.24 |
| Total Current Assets |
465,577,181.88 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
119,875,338.60 |
| Investment Properties |
143,784,848.09 |
| Fixed Assetes |
23,592,706.27 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
30,888,203.38 |
| R&D expenses |
13,085,180.78 |
| Goodwill |
198,654,360.28 |
| Long-Term Deferred and Prepaid Expenses |
17,809,960.98 |
| Deferred Income Tax Assets |
17,518,706.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
569,959,259.49 |
| Total Assets |
1,035,536,441.37 |
| Short-Term Loans |
117,231,370.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
156,953,657.65 |
| Accounts Received In Advance |
9,200.00 |
| Employee Compensation Payable |
16,221,632.49 |
| Taxes Payable |
7,265,786.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,261,479.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,990,754.06 |
| Other Current Liabilities |
1,710,945.70 |
| Sub-Total of Current Liabilities |
377,376,045.91 |
| Long-term Loans |
69,583,923.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,138,761.62 |
| Deferred Income Tax Liabilities |
529,037.08 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
72,499,115.74 |
| Total Liabilities |
449,875,161.65 |
| Paid-In Capital(Or Share Stock) |
691,229,485.00 |
| Capital Surplus |
212,096,681.65 |
| Surplus Reserve |
17,963,300.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-343,497,739.19 |
| Minority Stockholder's Interest |
7,497,512.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
578,163,767.20 |
| Owner's Equity（Stockholder's Equity） |
585,661,279.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,035,536,441.37 |
